ASLN
ASLAN Pharmaceuticals

3,211
Mkt Cap
$0.00
Volume
806,352.00
52W High
$4.32
52W Low
$0.475
PE Ratio
-0.04
ASLN Fundamentals
Price
$0.60
Prev Close
$0.6999
Open
$0.63
50D MA
$0.60
Beta
0.51
Avg. Volume
0.00
P/B
-0.09
Loading...
Loading...
Aslan Pharmaceuticals Ltd. is a clinical-stage immunology biopharmaceutical company, which develops novel therapeutics. It focuses on atopic dermatitis, other immunology indications and autoimmune disease. Its pipeline includes ASLAN003 and Eblasakimab. The company was founded by Carl Aslan Jason Morton Firth, Mark McHale, and Jeffrey Tomlinson in 2010 and is headquartered in Singapore.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
N/A

Frequently Asked Questions

What is Market Cap of ASLAN Pharmaceuticals Ltd - ADR?
What is the 52-week high for ASLAN Pharmaceuticals Ltd - ADR?
What is the 52-week low for ASLAN Pharmaceuticals Ltd - ADR?
What is ASLAN Pharmaceuticals Ltd - ADR stock price today?
What was ASLAN Pharmaceuticals Ltd - ADR stock price yesterday?
What is the PE ratio of ASLAN Pharmaceuticals Ltd - ADR?
What is the Price-to-Book ratio of ASLAN Pharmaceuticals Ltd - ADR?
What is the 50-day moving average of ASLAN Pharmaceuticals Ltd - ADR?

Latest ASLN News

View

Advertisement|Remove ads.

Advertisement|Remove ads.